bioAffinity Technologies, Inc. 8-K

What Happened bioAffinity Technologies, Inc. announced in an 8-K that on December 19, 2025 it convened but adjourned its special meeting of stockholders without conducting any business because there were not enough shares present or represented by proxy to establish a quorum. The adjourned special meeting is scheduled to reconvene on Monday, January 19, 2026 at 8:00 a.m. Central Time.

Key Details

• Adjournment date: December 19, 2025 — meeting lacked a quorum and no business was conducted.
• Reconvened meeting date/time: January 19, 2026 at 8:00 a.m. Central Time.
• Record date for voting remains November 4, 2025.
• No changes were made to the proposals to be voted on; stockholders who already submitted proxies or voted need not take action. Proxy voting instructions are in the definitive proxy statement (Schedule 14A) filed November 7, 2025, available on SEC.gov and ProxyVote.com.

Why It Matters An adjournment for lack of quorum delays formal shareholder votes on the matters presented but does not change the proposals or who is eligible to vote (record date stays the same). Investors should note the new meeting date, confirm whether their proxy has been submitted, and follow the proxy statement instructions if they want to vote or change their vote before the reconvened meeting.